Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.
Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.
Aevis Victoria SA is a Switzerland-based investment holding company founded in 2006 and headquartered in Fribourg. It specializes in the healthcare, hospitality, lifestyle, and infrastructure sectors, operating primarily through its Hospitals, Hospitality, and Real Estate segments. The company manages a diverse portfolio that includes private hospitals, hotels, radiology institutes, pharmacies, urology centers, health centers, day clinics, and golf courses, employing around 4,731 people. Notable offerings encompass health management programs, lifestyle coaching, and anti-aging cosmeuticals under the Nescens brand, alongside specialized services such as ambulance operations, physiotherapy, ophthalmology, sports medicine, medical radiation, stem cells, cosmetics, parking, cleaning, sterilization, and IT support. Aevis Victoria SA also owns strategic real estate properties supporting its healthcare and hospitality activities, with sales predominantly generated in Switzerland—reaching 883 million CHF in 2024, led by healthcare at 685 million CHF. As a subsidiary of M.R.S.I. Medical Research, Services and Investments S.A., which holds 75.59% ownership, it plays a key role in Switzerland's investment landscape, fostering advancements in life-enhancing services.
The business is unprofitable at the operating level (-1.31% margin). The thesis depends entirely on whether and when it reaches sustainable profitability.
Revenue grew 18.4%, still solid.
Net debt of CHF 921M represents 188.9x FCF, leverage limits flexibility.
Profitability & Returns
Revenue (TTM)
CHF 1.20B
▲ +18.4% YoY
Net Income (TTM)
-CHF 26M
▼ -207.5% YoY
Op. Margin
-1.31%
▲ +1.1pp YoY
ROIC
-0.79%
▲ +0.4pp YoY
Cash Flow & Balance Sheet
FCF (TTM)
CHF 5M
▲ +125.9% YoY
Op. Cash Flow (TTM)
CHF 91M
▲ +408.3% YoY
Net Debt
CHF 921M
Cash & Equiv.
CHF 29M
3Y CAGR: +3.2%
3Y CAGR: -50.5%
Continue Research